Readers & Subscribers: Please see the Readers Note in the right column. We need financial assistance and/or corporate sponsors to help in continuing this public service. We will display your company banner ad for a modest contribution. If you are interested or have suggestions, please contact us at: info@ecobizport.com. If you would like to make an individual or company contribution by credit card (click here). Fill out the form (optional); insert "REGTrak" in the comment box; and click on the PayPal logo to make a contribution and submit the form. All contributors greater than $US100 will receive a free one-year subscription to our eNewsUSA daily environmental briefing report.
Federal Register
Vol. 74, No. 42
Thursday, March 5, 2009
Vol. 74, No. 42
Thursday, March 5, 2009
There are 3 announcements in this issue
1. AIR - PR. EPA. National Emission Standards for Hazardous Air Pollutants for Reciprocating Internal Combustion Engines
2. TRANSPORT - ND. DOT/Federal Transit Administration. American Recovery and Reinvestment Act of 2009 Public Transportation Apportionments, Allocations and Grant Program Information
3. TOXICS - NM. DHHS/FDA. Risk Communication Advisory Committee; Notice of Meeting
CODES USED: THE FOLLOWING CODES ARE USED TO IDENTIFY THE TYPE OF ANNOUNCEMENT & ISSUE AREA.
REPORTING FORMAT: ISSUE CODE - TYPE CODE. AGENCY. ANNOUNCEMENT.
ISSUE CODES: AIR - Air; ALL - Cross-Media, ecosystems, Env. Justice; CLIMATE - Climate Change, Global Warming; DRINK - Drinking Water, SDWA, Underground Injection; ENERGY - Energy; GLAKES - Great Lakes; HAZ - Hazardous Waste, RCRA, HSWA, DOT/RSPA, Some Nuclear (NRC); LAND - Land Use, Forests; P2 - Pollution Prevention, Sustainability, Recycling, Pjt. XL; REMED - Remediation, Brownfields, Superfund; TANKS - AST, UST; TOXICS = Toxics, TRI, TSCA, Pesticides, Risks, RTK; TRANSPORT - Transportation; SOLID - Solid Waste, RCRA Subtitle D; WATER - Surface Water, NPS, NPDES, Wetlands; WILDLIFE = Wildlife, Biodiversity, Endangered Species.
TYPE CODES: ANPR - Advance Notice of Proposed Rulemaking; FR - Final Rule; FRD - Direct final rule; FRI - Interim final rule; ICR - Information Collection Request; ND - Notice of data, information, reports, etc. availability; NF - Notice of Fuding Opportunity; NM - Notice of Meeting; NS - Notice of administrative/court settlement; PR - Proposed Rule; ROD - Record of decision.
ANNOUNCEMENT 1
Subject: AIR - PR. EPA. National Emission Standards for Hazardous Air Pollutants for Reciprocating Internal Combustion Engines
[Federal Register: March 5, 2009 (Volume 74, Number 42)]
[Proposed Rules]
[Page 9697-9731]
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 63
[EPA-HQ-OAR-2008-0708, FRL-8778-6]
RIN 2060-AP36
National Emission Standards for Hazardous Air Pollutants for
Reciprocating Internal Combustion Engines
AGENCY: Environmental Protection Agency (EPA).
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: EPA is proposing national emission standards for hazardous air
pollutants for existing stationary reciprocating internal combustion
engines that either are located at area sources of hazardous air
pollutant emissions or that have a site rating of less than or equal to
500 brake horsepower and are located at major sources of hazardous air
pollutant emissions. In addition, EPA is proposing national emission
standards for hazardous air pollutants for existing stationary
compression ignition engines greater than 500 brake horsepower that are
located at major sources, based on a new review of these engines
following the first RICE NESHAP rulemaking in 2004. In addition, EPA is
proposing to amend the previously promulgated regulations regarding
operation of stationary reciprocating internal combustion engines
during periods of startup, shutdown and malfunction.
DATES: Comments must be received on or before May 4, 2009, or 30 days
after date of public hearing if later. Under the Paperwork Reduction
Act, comments on the information collection provisions must be received
by the Office of Management and Budget (OMB) on or before April 6,
2009.
Public Hearing. If anyone contacts us requesting to speak at a
public hearing by March 25, 2009, a public hearing will be held on
April 6, 2009. If you are interested in attending the public hearing,
contact Ms. Pamela Garrett at (919) 541-7966 to verify that a hearing
will be held.
ADDRESSES: Submit your comments, identified by Docket ID No. EPA-HQ-
OAR-2008-0708, by one of the following methods:
http://www.regulations.gov: Follow the on-line
instructions for submitting comments.
E-mail: a-and-r-docket@epa.gov.
Fax: (202) 566-1741.
Mail: Air and Radiation Docket and Information Center,
Environmental Protection Agency, Mailcode: 6102T, 1200 Pennsylvania
Ave., NW., Washington, DC 20460. Please include a total of two copies.
EPA requests a separate copy also be sent to the contact person
identified below (see FOR FURTHER INFORMATION CONTACT). In addition,
please mail a copy of your comments on the information collection
provisions to the Office of Information and Regulatory Affairs, Office
of Management and Budget, Attn: Desk Officer for EPA, 725 17th St.,
NW., Washington, DC 20503.
Hand Delivery: Air and Radiation Docket and Information
Center, U.S. EPA, Room B102, 1301 Constitution Avenue, NW., Washington,
DC. Such deliveries are only accepted during the Docket's normal hours
of operation, and special arrangements should be made for deliveries of
boxed information.
Instructions: Direct your comments to Docket ID No. EPA-HQ-OAR-
2008-0708. EPA's policy is that all comments received will be included
in the public docket without change and may be made available on-line
at http://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through http://
www.regulations.gov or e-mail. The http://www.regulations.gov Web site
is an ``anonymous access'' system, which means EPA will not know your
identity or contact information unless you provide it in the body of
your comment. If you send an e-mail comment directly to EPA without
going through http://www.regulations.gov, your e-mail address will be
automatically captured and included as part of the comment that is
placed in the public docket and made available on the Internet. If you
submit an electronic comment, EPA recommends that you include your name
and other contact information in the body of your comment and with any
disk or CD-ROM you submit. If EPA cannot read your comment due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comment. Electronic files should avoid
the use of special characters, any form of encryption, and be free of
any defects or viruses.
Public Hearing: If a public hearing is held, it will be held at
EPA's campus located at 109 T.W. Alexander Drive in Research Triangle
Park, NC or an alternate site nearby.
FOR FURTHER INFORMATION CONTACT: Mrs. Melanie King, Energy Strategies
Group, Sector Policies and Programs Division (D243-01), Environmental
Protection Agency, Research Triangle Park, North Carolina 27711;
telephone number (919) 541-2469; facsimile number (919) 541-5450; e-
mail address ``king.melanie@epa.gov.''
[Proposed Rules]
[Page 9697-9731]
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 63
[EPA-HQ-OAR-2008-0708, FRL-8778-6]
RIN 2060-AP36
National Emission Standards for Hazardous Air Pollutants for
Reciprocating Internal Combustion Engines
AGENCY: Environmental Protection Agency (EPA).
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: EPA is proposing national emission standards for hazardous air
pollutants for existing stationary reciprocating internal combustion
engines that either are located at area sources of hazardous air
pollutant emissions or that have a site rating of less than or equal to
500 brake horsepower and are located at major sources of hazardous air
pollutant emissions. In addition, EPA is proposing national emission
standards for hazardous air pollutants for existing stationary
compression ignition engines greater than 500 brake horsepower that are
located at major sources, based on a new review of these engines
following the first RICE NESHAP rulemaking in 2004. In addition, EPA is
proposing to amend the previously promulgated regulations regarding
operation of stationary reciprocating internal combustion engines
during periods of startup, shutdown and malfunction.
DATES: Comments must be received on or before May 4, 2009, or 30 days
after date of public hearing if later. Under the Paperwork Reduction
Act, comments on the information collection provisions must be received
by the Office of Management and Budget (OMB) on or before April 6,
2009.
Public Hearing. If anyone contacts us requesting to speak at a
public hearing by March 25, 2009, a public hearing will be held on
April 6, 2009. If you are interested in attending the public hearing,
contact Ms. Pamela Garrett at (919) 541-7966 to verify that a hearing
will be held.
ADDRESSES: Submit your comments, identified by Docket ID No. EPA-HQ-
OAR-2008-0708, by one of the following methods:
instructions for submitting comments.
Environmental Protection Agency, Mailcode: 6102T, 1200 Pennsylvania
Ave., NW., Washington, DC 20460. Please include a total of two copies.
EPA requests a separate copy also be sent to the contact person
identified below (see FOR FURTHER INFORMATION CONTACT). In addition,
please mail a copy of your comments on the information collection
provisions to the Office of Information and Regulatory Affairs, Office
of Management and Budget, Attn: Desk Officer for EPA, 725 17th St.,
NW., Washington, DC 20503.
Center, U.S. EPA, Room B102, 1301 Constitution Avenue, NW., Washington,
DC. Such deliveries are only accepted during the Docket's normal hours
of operation, and special arrangements should be made for deliveries of
boxed information.
Instructions: Direct your comments to Docket ID No. EPA-HQ-OAR-
2008-0708. EPA's policy is that all comments received will be included
in the public docket without change and may be made available on-line
at http://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through http://
www.regulations.gov or e-mail. The http://www.regulations.gov Web site
is an ``anonymous access'' system, which means EPA will not know your
identity or contact information unless you provide it in the body of
your comment. If you send an e-mail comment directly to EPA without
going through http://www.regulations.gov, your e-mail address will be
automatically captured and included as part of the comment that is
placed in the public docket and made available on the Internet. If you
submit an electronic comment, EPA recommends that you include your name
and other contact information in the body of your comment and with any
disk or CD-ROM you submit. If EPA cannot read your comment due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comment. Electronic files should avoid
the use of special characters, any form of encryption, and be free of
any defects or viruses.
Public Hearing: If a public hearing is held, it will be held at
EPA's campus located at 109 T.W. Alexander Drive in Research Triangle
Park, NC or an alternate site nearby.
FOR FURTHER INFORMATION CONTACT: Mrs. Melanie King, Energy Strategies
Group, Sector Policies and Programs Division (D243-01), Environmental
Protection Agency, Research Triangle Park, North Carolina 27711;
telephone number (919) 541-2469; facsimile number (919) 541-5450; e-
mail address ``king.melanie@epa.gov.''
ACCESS THE COMPLETE PUBLISHED ANNOUNCEMENT IN HTML OR PDF FORMATS AT:
ANNOUNCEMENT 2
Subject: TRANSPORT - ND. DOT/Federal Transit Administration. American Recovery and Reinvestment Act of 2009 Public Transportation Apportionments, Allocations and Grant Program Information
[Federal Register: March 5, 2009 (Volume 74, Number 42)]
[Notices]
[Page 9656-9691]
DEPARTMENT OF TRANSPORTATION
Federal Transit Administration
American Recovery and Reinvestment Act of 2009 Public
Transportation Apportionments, Allocations and Grant Program
Information
AGENCY: Federal Transit Administration (FTA), DOT.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The ``American Recovery and Reinvestment Act, 2009'' (Pub. L.
111-5; ``ARRA''), signed into law by President Barack Obama on February
17, 2009, includes $8.4 billion for transit capital improvements. This
notice implements the transit formula program related provisions of the
ARRA and provides program and grant application requirements for these
funds, to be made available through Federal Transit Administration
(FTA) assistance programs. Additional notices will be published in the
near future for the transit discretionary program provisions in the
ARRA.
DATES: Complete grant applications must be submitted in TEAM by July 1,
2009. FTA must reallocate certain unobligated funds by September 1,
2009.
FOR FURTHER INFORMATION CONTACT: For general information about this
notice contact Henrika Buchanan-Smith, Director, Office of Transit
Programs, at (202) 366-2053. Please contact the appropriate FTA
regional or metropolitan office (Appendix C) for any specific requests
for information or technical assistance. An FTA headquarters contact
for each major program area also is included in the discussion of that
program in the text of the notice.
[Notices]
[Page 9656-9691]
DEPARTMENT OF TRANSPORTATION
Federal Transit Administration
American Recovery and Reinvestment Act of 2009 Public
Transportation Apportionments, Allocations and Grant Program
Information
AGENCY: Federal Transit Administration (FTA), DOT.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The ``American Recovery and Reinvestment Act, 2009'' (Pub. L.
111-5; ``ARRA''), signed into law by President Barack Obama on February
17, 2009, includes $8.4 billion for transit capital improvements. This
notice implements the transit formula program related provisions of the
ARRA and provides program and grant application requirements for these
funds, to be made available through Federal Transit Administration
(FTA) assistance programs. Additional notices will be published in the
near future for the transit discretionary program provisions in the
ARRA.
DATES: Complete grant applications must be submitted in TEAM by July 1,
2009. FTA must reallocate certain unobligated funds by September 1,
2009.
FOR FURTHER INFORMATION CONTACT: For general information about this
notice contact Henrika Buchanan-Smith, Director, Office of Transit
Programs, at (202) 366-2053. Please contact the appropriate FTA
regional or metropolitan office (Appendix C) for any specific requests
for information or technical assistance. An FTA headquarters contact
for each major program area also is included in the discussion of that
program in the text of the notice.
ANNOUNCEMENT 3
Subject: TOXICS - NM. DHHS/FDA. Risk Communication Advisory Committee; Notice of Meeting
[Federal Register: March 5, 2009 (Volume 74, Number 42)]
[Notices]
[Page 9619-9620]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0664]
Risk Communication Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Risk Communication Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on April 30, 2009, from 8
a.m. to 5 p.m. and May 1, 2009, from 8 a.m. to 2 p.m.
Location: Food and Drug Administration, Center for Drug Evaluation
and Research Advisory Committee Conference Room, rm. 1066, 5630 Fishers
Lane, Rockville, MD.
Contact Person: Lee L. Zwanziger, Office of the Commissioner,
Office of Policy, Planning and Preparedness, Office of Planning, Food
and Drug Administration, 5600 Fishers Lane, rm 14-90, Rockville, MD
20857, telephone: 301-827-2895, FAX: 301-827-4050, e-mail:
RCAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area), code 8732112560.
Please call the Information Line for up-to-date information on this
meeting. A notice in the Federal Register about last minute
modifications that impact a previously announced advisory committee
meeting cannot always be published quickly enough to provide timely
notice. Therefore, you should always check the agency's Web site and
call the appropriate advisory committee hot line/phone line to learn
about possible modifications before coming to the meeting.
Agenda: On both days the Committee will discuss the Agency's draft
risk communication strategic plan and will be asked for comment and
further advice, for example, on strategic priorities for research on
effective risk communication.
FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm, click on
the year 2009 and scroll down to the appropriate advisory committee
link.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
April 23, 2009. Oral presentations from the public will be scheduled
between approximately 1 p.m. and 2 p.m. on April 30th and 10:30 to
11:30 a.m. on May 1st. Those desiring to make formal oral presentations
should notify the contact person on or before April 23, 2009, and
should submit a brief statement of the general nature of the evidence
or arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation. Time allotted for each presentation may be
limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person will
notify interested persons regarding their request to speak by April 24,
2009.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Lee L. Zwanziger at
least 7 days in advance of the meeting.
FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/
default.htm for procedures on public conduct during advisory committee
meetings.
[Notices]
[Page 9619-9620]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0664]
Risk Communication Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Risk Communication Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on April 30, 2009, from 8
a.m. to 5 p.m. and May 1, 2009, from 8 a.m. to 2 p.m.
Location: Food and Drug Administration, Center for Drug Evaluation
and Research Advisory Committee Conference Room, rm. 1066, 5630 Fishers
Lane, Rockville, MD.
Contact Person: Lee L. Zwanziger, Office of the Commissioner,
Office of Policy, Planning and Preparedness, Office of Planning, Food
and Drug Administration, 5600 Fishers Lane, rm 14-90, Rockville, MD
20857, telephone: 301-827-2895, FAX: 301-827-4050, e-mail:
RCAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area), code 8732112560.
Please call the Information Line for up-to-date information on this
meeting. A notice in the Federal Register about last minute
modifications that impact a previously announced advisory committee
meeting cannot always be published quickly enough to provide timely
notice. Therefore, you should always check the agency's Web site and
call the appropriate advisory committee hot line/phone line to learn
about possible modifications before coming to the meeting.
Agenda: On both days the Committee will discuss the Agency's draft
risk communication strategic plan and will be asked for comment and
further advice, for example, on strategic priorities for research on
effective risk communication.
FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm, click on
the year 2009 and scroll down to the appropriate advisory committee
link.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
April 23, 2009. Oral presentations from the public will be scheduled
between approximately 1 p.m. and 2 p.m. on April 30th and 10:30 to
11:30 a.m. on May 1st. Those desiring to make formal oral presentations
should notify the contact person on or before April 23, 2009, and
should submit a brief statement of the general nature of the evidence
or arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation. Time allotted for each presentation may be
limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person will
notify interested persons regarding their request to speak by April 24,
2009.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Lee L. Zwanziger at
least 7 days in advance of the meeting.
FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/
default.htm for procedures on public conduct during advisory committee
meetings.
